Axitinib

Axitinib

Axitinib is a potent, multi-targeted tyrosine kinase inhibitor of VEGFR1-3, PDGFRβ, and c-Kit. It inhibits VEGF-induced angiogenesis and reduces tumor growth in various xenograft models. Axitinib is clinically used for renal cell carcinoma treatment. Reagent grade, for research use only.

Molecular structure of the compound BP-43627
    • Unit
    • Price
    • Qty
    • 500 MG
    • $120.00
    • 1 G
    • $210.00
    • 5 G
    • $630.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire